You are here

Clinical Trials: Vascular Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, September 12, 2019 - 12:00
Condition:   Chronic Stroke
Intervention:   Drug: GXNPC1
Sponsor:   Gwo Xi Stem Cell Applied Technology Co., Ltd.
Not yet recruiting
Posted: Wednesday, August 14, 2019 - 12:00
Condition:   Acute Myocardial Infarction
Intervention:   Biological: Allogeneic umbilical cord mesenchymal stem cells
Sponsor:   Ever Supreme Bio Technology Co., Ltd.
Posted: Friday, August 9, 2019 - 12:00
Condition:   Coronary Artery Disease
Intervention:   Biological: MCRcI® stem cells
Sponsors:   Honya Medical Inc;   Chang Gung Memorial Hospital
Posted: Thursday, August 8, 2019 - 12:00
Condition:   Myocardial Infarction
Intervention:   Biological: MiSaver®
Sponsors:   Honya Medical Inc;   Chung Shan Medical University
Posted: Tuesday, August 6, 2019 - 12:00
Conditions:   Cerebral Ischemia;   Cerebral Infarction;   Stroke, Acute
Interventions:   Drug: Normal Saline along with standard treatment;   Drug: PMZ-1620 (sovateltide) along with standard treatment
Sponsor:   Pharmazz, Inc.
Not yet recruiting
Posted: Wednesday, July 10, 2019 - 12:00
Conditions:   Stroke;   Umbilical Cord Blood;   Erythropoietin;   Safety;   Treatment Outcome
Interventions:   Drug: Umbilical cord blood infusion;   Drug: Erythropoietin injection;   Drug: Placebo umbilical cord blood infusion;   Drug: Placebo erythropoietin injection;   Procedure: Active rehabilitation
Sponsors:   Bundang CHA Hospital;   Korea Evaluation Institute of Industrial Technology
Posted: Tuesday, June 11, 2019 - 12:00
Condition:   Central Retinal Vein Occlusion
Interventions:   Biological: Autologous Bone Marrow CD34+ Stem Cells;   Biological: Sham Therapy
Sponsors:   The Emmes Company, LLC;   National Eye Institute (NEI);   University of California, Davis
Not yet recruiting
Posted: Thursday, May 16, 2019 - 12:00
Condition:   Coronary Artery Disease
Interventions:   Combination Product: PCI with BioMatrix Alpha™ stent;   Combination Product: PCI with Combo™ stent
Sponsors:   Phillip Freeman;   Aarhus University Hospital;   Odense University Hospital;   OrbusNeich;   Biosensors International
Not yet recruiting
Posted: Wednesday, April 24, 2019 - 12:00
Condition:   Ischemic Heart Disease
Interventions:   Biological: Human Allogeneic Mesenchymal Bone Marrow Cells (aMBMC);   Other: Placebo
Sponsor:   Rebecca Torguson
Not yet recruiting
Posted: Tuesday, April 16, 2019 - 12:00
Condition:   Diabetes Mellitus Foot Ulcer
Intervention:   Biological: MSCs treatment
Sponsor:   Maoquan Li
Not yet recruiting